-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Description
AICAR (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside) is a substance produced naturally by the body that stimulates AMP activated protein kinase (AMPK), a protein that regulates metabolism in a variety of ways. AMPK acts as an energy regulator and is activated during exercise or other circumstances that use up cellular energy.
The AMPK-stimulating AICAR can also be synthesized in a lab and is being evaluated in preclinical research and human clinical trials as a therapeutic agent to treat certain metabolic disorders in humans.
Cell-permeable, allosteric activator of AMP-activated protein kinase (AMPK). Augments proliferation, differentiation and mineralization of osteoblastic MC3T3-EI cells and attenuates psychosine-induced expression of proinflammatory cytokines and iNOS in astrocytes. Promotes osteogenic differentiation of hAMSCs and BM-MSCs in vitro.
The drug has also been shown as a potential treatment for diabetes by increasing the metabolic activity of tissues by changing the physical composition of muscle.

Clinical data
Product Name
AICA ribonucleotide, AICA ribonucleotide, ZMP
CAS
2627-69-2
Molar mass
258.2
MF
C9H14N4O5
Capacity/Bottle
50mg/vial
Shape
Lyophilized powder
How do AICAR and AMPK impact performance?
Once activated by AICAR, AMPK works to make energy more available. For example, it increases the usage of fat for energy and causes cells to make more mitochondria (the cells' powerhouses or energy creators). AMPK basically ensures that the various tissues in the body don't run out of energy.
There are many circumstances that activate AMPK naturally, including hypoxia (low oxygen levels during exercise or at elevation), hypoglycemia (low blood sugar with exercise or fasting), the use of cellular energy during muscle contraction, and anything that disrupts energy creation within cells.
The effects of activating AMPK are extremely complex since it is involved in so many different metabolic pathways of the body. To date, the medical community has not found a way to target AMPK in a way that allows for the treatment of diseases in humans, although research has suggested it plays a role in diabetes, heart disease, and cancer.
Benefit
Some of the potential benefits and applications of AICAR that have been explored in scientific research include:
● Metabolic Regulation: AICAR's activation of AMPK may help regulate cellular energy homeostasis. This could have implications for metabolic disorders, such as obesity and type 2 diabetes, where improving insulin sensitivity and glucose uptake are important.
● Exercise Performance: AICAR has been studied for its potential to enhance endurance and exercise performance. Activation of AMPK may lead to increased energy production and utilization in skeletal muscles, potentially improving an athlete's capacity for aerobic exercise.
● Cardiovascular Health: Some research suggests that AICAR may have cardioprotective effects by promoting blood vessel health, reducing inflammation, and protecting against oxidative stress. These effects could be beneficial for individuals at risk of cardiovascular diseases.
● Neuroprotection: AICAR has been investigated for its potential neuroprotective properties, particularly in animal models of neurodegenerative diseases. It may support neuronal survival and function.
● Cancer Research: In laboratory studies, AICAR has been explored as a potential adjunctive therapy for cancer. It may inhibit the growth of cancer cells and promote their apoptosis (programmed cell death).
How does AICAR activates AMPK?
AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) is known to activate AMP-activated protein kinase (AMPK) through a mechanism involving its conversion into a molecule that mimics the effects of AMP (adenosine monophosphate), one of the natural activators of AMPK. Here's a simplified explanation of how AICAR activates AMPK:
Metabolic Stress: When a cell experiences metabolic stress, such as low energy levels or high energy demand (e.g., during exercise or calorie restriction), the ratio of AMP to ATP (adenosine triphosphate) increases. ATP is the primary cellular energy currency, while AMP is produced when ATP is broken down.
Activation of AMPK: Under conditions of increased AMP/ATP ratio, AMPK becomes activated as a response to the cell's energy deficit. AMPK is sensitive to changes in this ratio, and its activation triggers a series of cellular responses aimed at restoring energy balance.
AICAR Conversion: AICAR is a synthetic molecule that, when taken up by cells, can be converted into ZMP (5-aminoimidazole-4-carboxamide ribotide), a compound that closely resembles AMP in structure.
Mimicking AMP: ZMP effectively mimics the presence of AMP within the cell. When ZMP levels rise due to the conversion of AICAR, it signals to AMPK as if there is an energy deficit similar to what would occur during times of metabolic stress.
AMPK Activation: In response to the increased ZMP levels, AMPK becomes activated, initiating a cascade of intracellular events. Activated AMPK promotes processes that help restore energy balance, such as increasing glucose uptake, fatty acid oxidation, and inhibiting energy-consuming pathways.
Metabolic Effects: The activation of AMPK by AICAR or by the natural rise in AMP/ATP ratio under metabolic stress can have various effects, including the promotion of energy production, enhancement of insulin sensitivity, regulation of appetite, and potential benefits for exercise performance and metabolic health.
It's important to note that the activation of AMPK by AICAR is considered pharmacological, and AICAR itself is not a natural compound found in the body.
Why is AICAR on the World Anti-Doping Agency (WADA) Prohibited List?
AICAR is prohibited because it's an AMPK activator, which are prohibited at all times under the category of Hormone and Metabolic Modulators on the WADA Prohibited List because of their potential performance-enhancing effects.
-
Are there health risks to using AICAR?
Some articles refer to AMPK activators as "exercise-in-a-pill" in the hope that using an AMPK activator will cause the same changes in the body as exercise. However, the truth is much more complex.
Too much activation of AMPK, or activating it in the wrong tissue, can cause serious side effects, including neurodegeneration, or preventing cells from dividing. The accumulation of naturally-occurring AICAR in the body is also associated with metabolic disorders in humans.
However, AICAR has not been extensively studied in people. For this reason and many others, AICAR is an experimental compound that is not yet approved for therapeutic use in humans and should not be used by any athletes.
Our Advantages
1.Quality:every item is strictly tested by our professional staff and get ISO certificate.
2.Price: much lower than our peers since we are factory. A discount would be given when you make a large order.
3.Delivery: We have adequate stock so we can make the delivery within 24 hours after payment.
4.Perfect Reshipping policy has been made to protect customers max bennefits and reduce the potentical losses.
5.Good after-sale service: always keeping track on the status of your parcel until delivered and trying our utmost to solve customers problems entounered
6.main products:Raw steroids,human growth hormone,Semi-finished oils,bodybuilding peptides,SARMs raws,Anabolic steroids -
-
Any needs, please contact me
Email: amyraws195@gmail.com
Whatsapp/Telegram: +852 56445864


-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hot Tags: aicar cas:2627-69-2, China aicar cas:2627-69-2 manufacturers, suppliers, factory, High Quality MT2 Melanotan 2 Peptide, CAS 77591 33 4, CJC 1295 Without DAC CAS 863288 34 0, GDF 8 CAS 901758 09 6, CJC1295 DAC Human Growth Peptides, 2mg Vial Human Growth Peptides Hormonew PEG MGF












